Sygnis Pharma Ag


By |


SYGNIS AG is engaged in the development of novel, superior tools for molecular biology. Its developed products include SensiPhi/QualiPhi, a novel DNA polymerase licensed to QIAGEN.

Contact Information

Main Phone: +49 32221091975
Address: Waldhofer Strasse 104
City / Town: Heidelberg
Country: DEU
Postal Code: 69123

Issuer Information

Exchange: GREY
Employees: 21
$ 1.70 $ 0. (0.00%)
Last Price 1.70 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 1.70
Last Trade Volume 0 52 Wk Hi 1.70 52 Wk Low 1.47
Market Cap 64.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 37,860,336.00 EPS (TTM) -0.21 PE Ratio N/A Exchange Greys